The project represents a legitimate, high-value medical innovation (DualDur) with verified EU Horizon 2020 funding (€2.77M) and CE-marked commercialization in Europe. While the technology addresses a critical gap in Lyme disease diagnostics with significant potential, the submission itself was of low quality (e.g., user handle 'ShadowFang', false traction claim 'most people', and numeric email). The score reflects the strong underlying verification of the company and technology, heavily penalized by the unreliable user-supplied data regarding traction and reach.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline